Novavax, UK terminate vaccine supply agreement
(Reuters) -Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency (UKHSA) related to its COVID-19 vaccine supply agreement.
Under terms of the deal, the company and the UKHSA agreed to settle the outstanding amount under dispute related to upfront payments received by Novavax from the health agency.
Novavax has agreed to refund $123.8 million to the health agency in equal quarterly installments of $10.3 million over a three-year period, ending on June 30, 2027, a filing showed.
The first installment payment is due on Nov. 30.
(Reporting by Sneha S K; Editing by Shailesh Kuber)
More
What Trump’s return or a new Harris administration would mean for Switzerland
More
Documentary portrays Swiss teenagers forced to return to parents’ homeland
More
Love at new heights: Swiss hiker creates ‘Tinder for the mountains’
More
Gold-digging: why some Swiss bury their wealth in the garden
